Showing results (851-860 of 3,081) with videos related to
Sort By:
Pageof 309
Drug Safety|November 24, 2004
Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarctionRaymond G Schlienger, Lorenz M Fischer, Hershel Jick, et al.Drug Safety|December 14, 2004
Linking pharmacovigilance with pharmacogeneticsDavid W J Clark, Emma Donnelly, David M Coulter, et al.Drug Safety|December 14, 2004
Safety issues regarding colonic cleansing for diagnostic and surgical proceduresLarry E Clark, Jack A DipalmaDrug Safety|January 15, 2005
Atypical antipsychotics: from potassium channels to torsade de pointes and sudden deathKarine Titier, Pierre-Olivier Girodet, Hélène Verdoux, et al.Drug Safety|January 15, 2005
Hepatotoxicity of antiretrovirals: incidence, mechanisms and managementMarina Núñez, Vincent SorianoDrug Safety|March 1, 2005
Prevalence of potentially severe drug-drug interactions in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapyAlexandra E Rätz Bravo, Lydia Tchambaz, Anita Krähenbühl-Melcher, et al.Drug Safety|May 15, 2004
Do some inhibitors of COX-2 increase the risk of thromboembolic events?: Linking pharmacology with pharmacoepidemiologyDavid W J Clark, Deborah Layton, Saad A W ShakirDrug Safety|May 18, 2004
Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agentsJoan-Ramon Laporte, Luisa Ibáñez, Xavier Vidal, et al.Drug Safety|May 25, 2004
Communication of medical product risk: how effective is effective enough?Stephen A GoldmanPageof 309